Massachusetts H2223 mandates informed consent for benzodiazepine and non-benzodiazepine hypnotic prescriptions and establishes a commission to study.
Massachusetts H2223 requires practitioners to obtain written informed consent from patients before prescribing benzodiazepines and non-benzodiazepine hypnotics. The consent form must include information about misuse, dependency, addiction, and long-term use risks. Pharmacists must provide educational pamphlets when dispensing these drugs, detailing similar risks and resources for addiction support. The bill also mandates cautionary statements on labels for prescriptions of less than a 10-day supply and prohibits refills for such prescriptions.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.